Dow Up0.34% Nasdaq Up0.43%

Enzon Pharmaceuticals Inc. (ENZN)

-NasdaqCM
1.07 Down 0.01(0.93%) 11:16AM EST - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 34,493   42,600   48,072  
Cost of Revenue -   -   -  
Gross Profit 34,493   42,600   48,072  
Operating Expenses
Research Development2,715  21,005  41,106  
Selling General and Administrative8,843  14,475  17,396  
Non Recurring4,776  11,086  6,025  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 18,159   (3,966) (16,455)
Income from Continuing Operations
Total Other Income/Expenses Net2,087  2,378  1,826  
Earnings Before Interest And Taxes20,246  (1,588)(14,629)
Interest Expense2,124  5,330  5,929  
Income Before Tax18,122  (6,918)(20,558)
Income Tax Expense(28)(4,135)205  
Minority Interest -   -   -  
Net Income From Continuing Ops18,150  (2,783)(20,763)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 18,150   (2,783) (20,763)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 18,150   (2,783) (20,763)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.